Back to Search
Start Over
Drug-induced hypothyroidism in tuberculosis.
- Source :
- Expert Review of Endocrinology & Metabolism; May2024, Vol. 19 Issue 3, p199-206, 8p
- Publication Year :
- 2024
-
Abstract
- Adverse reactions to tuberculosis treatment can impact patient adherence and prognosis. Hypothyroidism is a frequent adverse reaction caused using ethionamide, prothionamide, and para-aminosalicylic acid and is often underdiagnosed. We searched Scielo, Scopus, and EMBASE databases, including 67 articles. Antitubercular drug-induced hypothyroidism has a prevalence of 17%. It occurs after 2 to 3 months of treatment and resolves within 4 to 6 weeks after discontinuation. It is postulated to result from the inhibition of thyroperoxidase function, blocking thyroid hormone synthesis. Symptoms are nonspecific, necessitating individualized thyroid-stimulating hormone measurement for detection. Specific guidelines for management are lacking, but initiation of treatment with levothyroxine, as is customary for primary hypothyroidism, is recommended. Discontinuation of antitubercular drugs is discouraged, as it may lead to unfavorable consequences. Antitubercular drug-induced hypothyroidism is more common than previously thought, affecting one in six MDR-TB patients. Despite diagnostic and treatment recommendations, implementation is hindered in low-income countries due to the lack of certified laboratories. New drugs for tuberculosis treatment may affect thyroid function, requiring vigilant monitoring for complications, including hypothyroidism. [ABSTRACT FROM AUTHOR]
- Subjects :
- HYPOTHYROIDISM
DRUG side effects
TUBERCULOSIS
HORMONE synthesis
LOW-income countries
Subjects
Details
- Language :
- English
- ISSN :
- 17446651
- Volume :
- 19
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Expert Review of Endocrinology & Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 177179255
- Full Text :
- https://doi.org/10.1080/17446651.2024.2307525